« Back
Home /
Monoclonal Antibody to Serine/threonine-protein kinase mTOR (mTOR)

Monoclonal Antibody to Serine/threonine-protein kinase mTOR (mTOR)

Item no.	MAB806Hu21-200ul
Manufacturer	Cloud-Clone
Amount	200 ul
Quantity options	100 ul 1 ml 200 ul 20 ul 500 ul
Category	Oncology Metabolism Diabetes Antibodies By Cell Type Carcinoma Glioma Hematology Leukemia Lymphoma Myeloma Melanoma Cell Biology Cell Status Cytoskeleton Immunohistochemistry Immunoprecipitation Western Blot Immunocytochemistry Autophagy Primary Antibodies small GTPases Ras Subfamily Rap Subfamily
Type	Antibody Monoclonal
Format	Liquid
Applications	WB, IHC
Clone	D7
Specific against	Human (Homo sapiens)
Host	Mouse
Isotype	IgG2b Kappa
ECLASS 10.1	42030590
ECLASS 11.0	42030590
UNSPSC	12352203
Alias	FRAP,FRAP1,FRAP2,MTOR,RAFT1,RAPT1,FK506 Binding Protein 12 Rapamycin Associated Protein,Mammalian Target Of Rapamycin,FKBP12-Rapamycin Complex-Associated Protein 1,Rapamycin and FKBP12 target
Available
Manufacturer - Category	Primary Ab
Manufacturer - Research Area	Tumor immunity,
Buffer Formulation	PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Immunogen	RPB806Hu01-Recombinant Serine/threonine-protein kinase mTOR (mTOR)
Usage	Western blotting: 0.01-2µg/mL; < br/> Immunohistochemistry: 5-20µg/mL; < br/> Optimal working dilutions must be determined by end user.
Purification	Protein A + Protein G affinity chromatography

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.